Correlates of clinical restenosis following intracoronary implantation of drug-eluting stents.

[1]  William Wijns,et al.  Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern. , 2007, Circulation.

[2]  Patrick Hunziker,et al.  Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. , 2006, Journal of the American College of Cardiology.

[3]  Seung‐Jung Park,et al.  Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up. , 2006, The American journal of cardiology.

[4]  Hong Wang,et al.  Periprocedural and late consequences of overlapping Cypher sirolimus-eluting stents: pooled analysis of five clinical trials. , 2006, Journal of the American College of Cardiology.

[5]  A. Kastrati,et al.  Predictive Factors of Restenosis After Coronary Implantation of Sirolimus- or Paclitaxel-Eluting Stents , 2006, Circulation.

[6]  Seung‐Jung Park,et al.  Predictors of restenosis after placement of drug-eluting stents in one or more coronary arteries. , 2006, The American journal of cardiology.

[7]  K. Seung,et al.  Comparison of sirolimus‐eluting stent, paclitaxel‐eluting stent, and bare metal stent in the treatment of long coronary lesions , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[8]  P. Serruys,et al.  "Full metal jacket" (stented length > or =64 mm) using drug-eluting stents for de novo coronary artery lesions. , 2005, American heart journal.

[9]  P. Fitzgerald,et al.  Predictors of edge stenosis following sirolimus-eluting stent deployment (a quantitative intravascular ultrasound analysis from the SIRIUS trial). , 2005, The American journal of cardiology.

[10]  J. Valencia,et al.  Incidence and predictors of restenosis after sirolimus-eluting stent implantation in high-risk patients. , 2005, American heart journal.

[11]  I. Iakovou,et al.  Multiple overlapping drug-eluting stents to treat diffuse disease of the left anterior descending coronary artery. , 2005, Journal of the American College of Cardiology.

[12]  Marco Valgimigli,et al.  The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry. , 2005, Journal of the American College of Cardiology.

[13]  J. Schofer,et al.  Coronary restenosis after implantation of drug-eluting stents. , 2005, Minerva cardioangiologica.

[14]  Patrick W Serruys,et al.  Clinical, Angiographic, and Procedural Predictors of Angiographic Restenosis After Sirolimus-Eluting Stent Implantation in Complex Patients: An Evaluation From the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) Study , 2004, Circulation.

[15]  P. Teirstein,et al.  Contribution of Stent Underexpansion to Recurrence After Sirolimus-Eluting Stent Implantation for In-Stent Restenosis , 2004, Circulation.

[16]  P. Fitzgerald,et al.  1139-55 Optimal geometry is still important with sirolimus-eluting stents: Incomplete stent expansion as a risk for target lesion revascularization , 2004 .

[17]  I. Iakovou,et al.  1044-55 Overdilation of cypher 3.0 mm 6 cells stent: Clinical consequences , 2004 .

[18]  G. Stone,et al.  A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. , 2004, The New England journal of medicine.

[19]  Jeffrey W Moses,et al.  Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. , 2003, The New England journal of medicine.

[20]  Gary S. Mintz,et al.  Intravascular Ultrasound Guidance Improves Angiographic and Clinical Outcome of Stent Implantation for Long Coronary Artery Stenoses: Final Results of a Randomized Comparison With Angiographic Guidance (TULIP Study) , 2003, Circulation.

[21]  D. Baim,et al.  Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials. , 2002, Journal of the American College of Cardiology.

[22]  P. Serruys,et al.  A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. , 2002, The New England journal of medicine.

[23]  S. Marx,et al.  Bench to bedside: the development of rapamycin and its application to stent restenosis. , 2001, Circulation.

[24]  P. Teirstein,et al.  Final Results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) Study , 2000 .

[25]  M. Hadamitzky,et al.  Predictive factors of restenosis after coronary stent placement. , 1997, Journal of the American College of Cardiology.

[26]  D. Holmes,et al.  Coronary artery stents. , 2000, JAMA.

[27]  R. Donehower,et al.  Drug therapy : paclitaxel (Taxol) , 1995 .